Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Oxaliplatin Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Global Oxaliplatin Market Report, History and Forecast 2018-2029, Breakdown Data by Companies, Key Regions, Types and Application

Industry: Pharma & Healthcare

Published: 2023-05-24

Pages: 122 Pages

Report ld: 1207621

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

Oxaliplatin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Oxaliplatin market is projected to reach US$ 1641.5 million in 2029, increasing from US$ 897.5 million in 2022, with the CAGR of 8.9% during the period of 2023 to 2029. Demand from Colorectal Cancer and Stomach Cancer are the major drivers for the industry.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

The key players are Sanofi-Aventis, Yakult honsha, Dr Reddy's laboratories, Sun Pharmaceutical, Teva, Fresenius Kabi, Hospira, Mylan, Jiangsu Hengrui Medicine, Nanjing Pharmaceutical Factory, Jiangsu Aosaikang Pharmaceutical, Qilu Pharmaceutical, Hisun Pharmaceutical, Lunan Pharmaceutical, Luoxin, Halfsky Pharmacy, YRPG, Hainan Jinrui Pharmaceutical, Jari Pharmaceutical, Chiatai Tianqing etc. Top 3 companies occupied about 66% revenue market share.

Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oxaliplatin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Companies, Type, Application and Regions Listed in the Report:
By Company
Sanofi-Aventis
Yakult honsha
Dr Reddy's laboratories
Sun Pharmaceutical
Teva
Fresenius Kabi
Hospira
Mylan
Jiangsu Hengrui Medicine
Nanjing Pharmaceutical Factory
Jiangsu Aosaikang Pharmaceutical
Qilu Pharmaceutical
Hisun Pharmaceutical
Lunan Pharmaceutical
Luoxin
Halfsky Pharmacy
YRPG
Hainan Jinrui Pharmaceutical
Jari Pharmaceutical
Chiatai Tianqing

Segment by Type
Mannitol
Glucose Solution
Lactose Solution
Others

Segment by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE

Each chapter of the report provides detailed information for readers to understand the Oxaliplatin market further:
Chapter 1: Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029).
Chapter 2: Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3: Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4: Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Companies’ Outline, covering company’s basic information, Oxaliplatin introduction, etc. Oxaliplatin Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11: Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12: QYResearch’s Conclusions of Oxaliplatin market based on comprehensive survey.
Chapter 13: Methodology and Data Sources adopted by QYResearch.

 1 Market Overview of Oxaliplatin
    1.1 Oxaliplatin Market Overview
        1.1.1 Oxaliplatin Product Scope
        1.1.2 Oxaliplatin Market Status and Outlook
    1.2 Global Oxaliplatin Market Size Overview by Region 2018 VS 2022 VS 2029
    1.3 Global Oxaliplatin Market Size by Region (2018-2029)
    1.4 Global Oxaliplatin Historic Market Size by Region (2018-2023)
    1.5 Global Oxaliplatin Market Size Forecast by Region (2024-2029)
    1.6 Key Regions, Oxaliplatin Market Size (2018-2029)
        1.6.1 North America Oxaliplatin Market Size (2018-2029)
        1.6.2 Europe Oxaliplatin Market Size (2018-2029)
        1.6.3 Asia-Pacific Oxaliplatin Market Size (2018-2029)
        1.6.4 Latin America Oxaliplatin Market Size (2018-2029)
        1.6.5 Middle East & Africa Oxaliplatin Market Size (2018-2029)

 2 Oxaliplatin Market by Type
    2.1 Introduction
        2.1.1 Mannitol
        2.1.2 Glucose Solution
        2.1.3 Lactose Solution
        2.1.4 Others
    2.2 Global Oxaliplatin Market Size by Type: 2018 VS 2022 VS 2029
        2.2.1 Global Oxaliplatin Historic Market Size by Type (2018-2023)
        2.2.2 Global Oxaliplatin Forecasted Market Size by Type (2024-2029)
    2.3 Key Regions Market Size by Type
        2.3.1 North America Oxaliplatin Revenue Breakdown by Type (2018-2029)
        2.3.2 Europe Oxaliplatin Revenue Breakdown by Type (2018-2029)
        2.3.3 Asia-Pacific Oxaliplatin Revenue Breakdown by Type (2018-2029)
        2.3.4 Latin America Oxaliplatin Revenue Breakdown by Type (2018-2029)
        2.3.5 Middle East and Africa Oxaliplatin Revenue Breakdown by Type (2018-2029)

 3 Oxaliplatin Market Overview by Application
    3.1 Introduction
        3.1.1 Colorectal Cancer
        3.1.2 Stomach Cancer
        3.1.3 Ovarian Cancer
        3.1.4 Others
    3.2 Global Oxaliplatin Market Size by Application: 2018 VS 2022 VS 2029
        3.2.1 Global Oxaliplatin Historic Market Size by Application (2018-2023)
        3.2.2 Global Oxaliplatin Forecasted Market Size by Application (2024-2029)
    3.3 Key Regions Market Size by Application
        3.3.1 North America Oxaliplatin Revenue Breakdown by Application (2018-2029)
        3.3.2 Europe Oxaliplatin Revenue Breakdown by Application (2018-2029)
        3.3.3 Asia-Pacific Oxaliplatin Revenue Breakdown by Application (2018-2029)
        3.3.4 Latin America Oxaliplatin Revenue Breakdown by Application (2018-2029)
        3.3.5 Middle East and Africa Oxaliplatin Revenue Breakdown by Application (2018-2029)

 4 Oxaliplatin Competition Analysis by Players
    4.1 Global Oxaliplatin Market Size by Players (2018-2023)
    4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxaliplatin as of 2022)
    4.3 Date of Key Players Enter into Oxaliplatin Market
    4.4 Global Top Players Oxaliplatin Headquarters and Area Served
    4.5 Key Players Oxaliplatin Product Solution and Service
    4.6 Competitive Status
        4.6.1 Oxaliplatin Market Concentration Rate
        4.6.2 Mergers & Acquisitions, Expansion Plans

 5 Company (Top Players) Profiles
    5.1 Sanofi-Aventis
        5.1.1 Sanofi-Aventis Profile
        5.1.2 Sanofi-Aventis Main Business
        5.1.3 Sanofi-Aventis Oxaliplatin Products, Services and Solutions
        5.1.4 Sanofi-Aventis Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.1.5 Sanofi-Aventis Recent Developments
    5.2 Yakult honsha
        5.2.1 Yakult honsha Profile
        5.2.2 Yakult honsha Main Business
        5.2.3 Yakult honsha Oxaliplatin Products, Services and Solutions
        5.2.4 Yakult honsha Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.2.5 Yakult honsha Recent Developments
    5.3 Dr Reddy's laboratories
        5.3.1 Dr Reddy's laboratories Profile
        5.3.2 Dr Reddy's laboratories Main Business
        5.3.3 Dr Reddy's laboratories Oxaliplatin Products, Services and Solutions
        5.3.4 Dr Reddy's laboratories Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.3.5 Sun Pharmaceutical Recent Developments
    5.4 Sun Pharmaceutical
        5.4.1 Sun Pharmaceutical Profile
        5.4.2 Sun Pharmaceutical Main Business
        5.4.3 Sun Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.4.4 Sun Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.4.5 Sun Pharmaceutical Recent Developments
    5.5 Teva
        5.5.1 Teva Profile
        5.5.2 Teva Main Business
        5.5.3 Teva Oxaliplatin Products, Services and Solutions
        5.5.4 Teva Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.5.5 Teva Recent Developments
    5.6 Fresenius Kabi
        5.6.1 Fresenius Kabi Profile
        5.6.2 Fresenius Kabi Main Business
        5.6.3 Fresenius Kabi Oxaliplatin Products, Services and Solutions
        5.6.4 Fresenius Kabi Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.6.5 Fresenius Kabi Recent Developments
    5.7 Hospira
        5.7.1 Hospira Profile
        5.7.2 Hospira Main Business
        5.7.3 Hospira Oxaliplatin Products, Services and Solutions
        5.7.4 Hospira Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.7.5 Hospira Recent Developments
    5.8 Mylan
        5.8.1 Mylan Profile
        5.8.2 Mylan Main Business
        5.8.3 Mylan Oxaliplatin Products, Services and Solutions
        5.8.4 Mylan Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.8.5 Mylan Recent Developments
    5.9 Jiangsu Hengrui Medicine
        5.9.1 Jiangsu Hengrui Medicine Profile
        5.9.2 Jiangsu Hengrui Medicine Main Business
        5.9.3 Jiangsu Hengrui Medicine Oxaliplatin Products, Services and Solutions
        5.9.4 Jiangsu Hengrui Medicine Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.9.5 Jiangsu Hengrui Medicine Recent Developments
    5.10 Nanjing Pharmaceutical Factory
        5.10.1 Nanjing Pharmaceutical Factory Profile
        5.10.2 Nanjing Pharmaceutical Factory Main Business
        5.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Products, Services and Solutions
        5.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.10.5 Nanjing Pharmaceutical Factory Recent Developments
    5.11 Jiangsu Aosaikang Pharmaceutical
        5.11.1 Jiangsu Aosaikang Pharmaceutical Profile
        5.11.2 Jiangsu Aosaikang Pharmaceutical Main Business
        5.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
    5.12 Qilu Pharmaceutical
        5.12.1 Qilu Pharmaceutical Profile
        5.12.2 Qilu Pharmaceutical Main Business
        5.12.3 Qilu Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.12.4 Qilu Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.12.5 Qilu Pharmaceutical Recent Developments
    5.13 Hisun Pharmaceutical
        5.13.1 Hisun Pharmaceutical Profile
        5.13.2 Hisun Pharmaceutical Main Business
        5.13.3 Hisun Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.13.4 Hisun Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.13.5 Hisun Pharmaceutical Recent Developments
    5.14 Lunan Pharmaceutical
        5.14.1 Lunan Pharmaceutical Profile
        5.14.2 Lunan Pharmaceutical Main Business
        5.14.3 Lunan Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.14.4 Lunan Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.14.5 Lunan Pharmaceutical Recent Developments
    5.15 Luoxin
        5.15.1 Luoxin Profile
        5.15.2 Luoxin Main Business
        5.15.3 Luoxin Oxaliplatin Products, Services and Solutions
        5.15.4 Luoxin Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.15.5 Luoxin Recent Developments
    5.16 Halfsky Pharmacy
        5.16.1 Halfsky Pharmacy Profile
        5.16.2 Halfsky Pharmacy Main Business
        5.16.3 Halfsky Pharmacy Oxaliplatin Products, Services and Solutions
        5.16.4 Halfsky Pharmacy Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.16.5 Halfsky Pharmacy Recent Developments
    5.17 YRPG
        5.17.1 YRPG Profile
        5.17.2 YRPG Main Business
        5.17.3 YRPG Oxaliplatin Products, Services and Solutions
        5.17.4 YRPG Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.17.5 YRPG Recent Developments
    5.18 Hainan Jinrui Pharmaceutical
        5.18.1 Hainan Jinrui Pharmaceutical Profile
        5.18.2 Hainan Jinrui Pharmaceutical Main Business
        5.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.18.5 Hainan Jinrui Pharmaceutical Recent Developments
    5.19 Jari Pharmaceutical
        5.19.1 Jari Pharmaceutical Profile
        5.19.2 Jari Pharmaceutical Main Business
        5.19.3 Jari Pharmaceutical Oxaliplatin Products, Services and Solutions
        5.19.4 Jari Pharmaceutical Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.19.5 Jari Pharmaceutical Recent Developments
    5.20 Chiatai Tianqing
        5.20.1 Chiatai Tianqing Profile
        5.20.2 Chiatai Tianqing Main Business
        5.20.3 Chiatai Tianqing Oxaliplatin Products, Services and Solutions
        5.20.4 Chiatai Tianqing Oxaliplatin Revenue (US$ Million) & (2018-2023)
        5.20.5 Chiatai Tianqing Recent Developments

 6 North America
    6.1 North America Oxaliplatin Market Size by Country (2018-2029)
    6.2 U.S.
    6.3 Canada

 7 Europe
    7.1 Europe Oxaliplatin Market Size by Country (2018-2029)
    7.2 Germany
    7.3 France
    7.4 U.K.
    7.5 Italy
    7.6 Russia
    7.7 Nordic Countries
    7.8 Rest of Europe

 8 Asia-Pacific
    8.1 Asia-Pacific Oxaliplatin Market Size by Region (2018-2029)
    8.2 China
    8.3 Japan
    8.4 South Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australia
    8.8 Rest of Asia-Pacific

 9 Latin America
    9.1 Latin America Oxaliplatin Market Size by Country (2018-2029)
    9.2 Mexico
    9.3 Brazil
    9.4 Rest of Latin America

 10 Middle East & Africa
    10.1 Middle East & Africa Oxaliplatin Market Size by Country (2018-2029)
    10.2 Turkey
    10.3 Saudi Arabia
    10.4 UAE
    10.5 Rest of Middle East & Africa

 11 Oxaliplatin Market Dynamics
    11.1 Oxaliplatin Industry Trends
    11.2 Oxaliplatin Market Drivers
    11.3 Oxaliplatin Market Challenges
    11.4 Oxaliplatin Market Restraints

 12 Research Finding /Conclusion

 13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List

List of Tables
    Table 1. Global Market Oxaliplatin Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
    Table 2. Global Oxaliplatin Market Size by Region (2018-2023) & (US$ Million)
    Table 3. Global Oxaliplatin Market Size Share by Region (2018-2023)
    Table 4. Global Oxaliplatin Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 5. Global Oxaliplatin Forecasted Market Size Share by Region (2024-2029)
    Table 6. Global Oxaliplatin Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
    Table 7. Global Oxaliplatin Market Size by Type (2018-2023) & (US$ Million)
    Table 8. Global Oxaliplatin Revenue Market Share by Type (2018-2023)
    Table 9. Global Oxaliplatin Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 10. Global Oxaliplatin Revenue Market Share by Type (2024-2029)
    Table 11. North America Oxaliplatin Revenue by Type (2018-2023) & (US$ Million)
    Table 12. North America Oxaliplatin Revenue by Type (2024-2029) & (US$ Million)
    Table 13. Europe Oxaliplatin Revenue by Type (2018-2023) & (US$ Million)
    Table 14. Europe Oxaliplatin Revenue by Type (2024-2029) & (US$ Million)
    Table 15. Asia-Pacific Oxaliplatin Revenue by Type (2018-2023) & (US$ Million)
    Table 16. Asia-Pacific Oxaliplatin Revenue by Type (2024-2029) & (US$ Million)
    Table 17. Latin America Oxaliplatin Revenue by Type (2018-2023) & (US$ Million)
    Table 18. Latin America Oxaliplatin Revenue by Type (2024-2029) & (US$ Million)
    Table 19. Middle East and Africa Oxaliplatin Revenue by Type (2018-2023) & (US$ Million)
    Table 20. Middle East and Africa Oxaliplatin Revenue by Type (2024-2029) & (US$ Million)
    Table 21. Global Oxaliplatin Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
    Table 22. Global Oxaliplatin Market Size by Application (2018-2023) & (US$ Million)
    Table 23. Global Oxaliplatin Revenue Market Share by Application (2018-2023)
    Table 24. Global Oxaliplatin Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 25. Global Oxaliplatin Revenue Market Share by Application (2024-2029)
    Table 26. North America Oxaliplatin Revenue by Application (2018-2023) & (US$ Million)
    Table 27. North America Oxaliplatin Revenue by Application (2024-2029) & (US$ Million)
    Table 28. Europe Oxaliplatin Revenue by Application (2018-2023) & (US$ Million)
    Table 29. Europe Oxaliplatin Revenue by Application (2024-2029) & (US$ Million)
    Table 30. Asia-Pacific Oxaliplatin Revenue by Application (2018-2023) & (US$ Million)
    Table 31. Asia-Pacific Oxaliplatin Revenue by Application (2024-2029) & (US$ Million)
    Table 32. Latin America Oxaliplatin Revenue by Application (2018-2023) & (US$ Million)
    Table 33. Latin America Oxaliplatin Revenue by Application (2024-2029) & (US$ Million)
    Table 34. Middle East and Africa Oxaliplatin Revenue by Application (2018-2023) & (US$ Million)
    Table 35. Middle East and Africa Oxaliplatin Revenue by Application (2024-2029) & (US$ Million)
    Table 36. Global Oxaliplatin Revenue (US$ Million) by Players (2018-2023)
    Table 37. Global Oxaliplatin Revenue Market Share by Players (2018-2023)
    Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oxaliplatin as of 2022)
    Table 39. Date of Key Players Enter into Oxaliplatin Market
    Table 40. Global Oxaliplatin Key Players Headquarters and Area Served
    Table 41. Oxaliplatin Product Solution and Service
    Table 42. Global Oxaliplatin Players Market Concentration Ratio (CR5 and HHI)
    Table 43. Mergers & Acquisitions, Expansion Plans
    Table 44. Sanofi-Aventis Basic Information List
    Table 45. Sanofi-Aventis Description and Business Overview
    Table 46. Sanofi-Aventis Oxaliplatin Products, Services and Solutions
    Table 47. Revenue (US$ Million) in Oxaliplatin Business of Sanofi-Aventis (2018-2023)
    Table 48. Sanofi-Aventis Recent Developments
    Table 49. Yakult honsha Basic Information List
    Table 50. Yakult honsha Description and Business Overview
    Table 51. Yakult honsha Oxaliplatin Products, Services and Solutions
    Table 52. Revenue (US$ Million) in Oxaliplatin Business of Yakult honsha (2018-2023)
    Table 53. Yakult honsha Recent Developments
    Table 54. Dr Reddy's laboratories Basic Information List
    Table 55. Dr Reddy's laboratories Description and Business Overview
    Table 56. Dr Reddy's laboratories Oxaliplatin Products, Services and Solutions
    Table 57. Revenue (US$ Million) in Oxaliplatin Business of Dr Reddy's laboratories (2018-2023)
    Table 58. Dr Reddy's laboratories Recent Developments
    Table 59. Sun Pharmaceutical Basic Information List
    Table 60. Sun Pharmaceutical Description and Business Overview
    Table 61. Sun Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 62. Revenue (US$ Million) in Oxaliplatin Business of Sun Pharmaceutical (2018-2023)
    Table 63. Sun Pharmaceutical Recent Developments
    Table 64. Teva Basic Information List
    Table 65. Teva Description and Business Overview
    Table 66. Teva Oxaliplatin Products, Services and Solutions
    Table 67. Revenue (US$ Million) in Oxaliplatin Business of Teva (2018-2023)
    Table 68. Teva Recent Developments
    Table 69. Fresenius Kabi Basic Information List
    Table 70. Fresenius Kabi Description and Business Overview
    Table 71. Fresenius Kabi Oxaliplatin Products, Services and Solutions
    Table 72. Revenue (US$ Million) in Oxaliplatin Business of Fresenius Kabi (2018-2023)
    Table 73. Fresenius Kabi Recent Developments
    Table 74. Hospira Basic Information List
    Table 75. Hospira Description and Business Overview
    Table 76. Hospira Oxaliplatin Products, Services and Solutions
    Table 77. Revenue (US$ Million) in Oxaliplatin Business of Hospira (2018-2023)
    Table 78. Hospira Recent Developments
    Table 79. Mylan Basic Information List
    Table 80. Mylan Description and Business Overview
    Table 81. Mylan Oxaliplatin Products, Services and Solutions
    Table 82. Revenue (US$ Million) in Oxaliplatin Business of Mylan (2018-2023)
    Table 83. Mylan Recent Developments
    Table 84. Jiangsu Hengrui Medicine Basic Information List
    Table 85. Jiangsu Hengrui Medicine Description and Business Overview
    Table 86. Jiangsu Hengrui Medicine Oxaliplatin Products, Services and Solutions
    Table 87. Revenue (US$ Million) in Oxaliplatin Business of Jiangsu Hengrui Medicine (2018-2023)
    Table 88. Jiangsu Hengrui Medicine Recent Developments
    Table 89. Nanjing Pharmaceutical Factory Basic Information List
    Table 90. Nanjing Pharmaceutical Factory Description and Business Overview
    Table 91. Nanjing Pharmaceutical Factory Oxaliplatin Products, Services and Solutions
    Table 92. Revenue (US$ Million) in Oxaliplatin Business of Nanjing Pharmaceutical Factory (2018-2023)
    Table 93. Nanjing Pharmaceutical Factory Recent Developments
    Table 94. Jiangsu Aosaikang Pharmaceutical Basic Information List
    Table 95. Jiangsu Aosaikang Pharmaceutical Description and Business Overview
    Table 96. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 97. Revenue (US$ Million) in Oxaliplatin Business of Jiangsu Aosaikang Pharmaceutical (2018-2023)
    Table 98. Jiangsu Aosaikang Pharmaceutical Recent Developments
    Table 99. Qilu Pharmaceutical Basic Information List
    Table 100. Qilu Pharmaceutical Description and Business Overview
    Table 101. Qilu Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 102. Revenue (US$ Million) in Oxaliplatin Business of Qilu Pharmaceutical (2018-2023)
    Table 103. Qilu Pharmaceutical Recent Developments
    Table 104. Hisun Pharmaceutical Basic Information List
    Table 105. Hisun Pharmaceutical Description and Business Overview
    Table 106. Hisun Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 107. Revenue (US$ Million) in Oxaliplatin Business of Hisun Pharmaceutical (2018-2023)
    Table 108. Hisun Pharmaceutical Recent Developments
    Table 109. Lunan Pharmaceutical Basic Information List
    Table 110. Lunan Pharmaceutical Description and Business Overview
    Table 111. Lunan Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 112. Revenue (US$ Million) in Oxaliplatin Business of Lunan Pharmaceutical (2018-2023)
    Table 113. Lunan Pharmaceutical Recent Developments
    Table 114. Luoxin Basic Information List
    Table 115. Luoxin Description and Business Overview
    Table 116. Luoxin Oxaliplatin Products, Services and Solutions
    Table 117. Revenue (US$ Million) in Oxaliplatin Business of Luoxin (2018-2023)
    Table 118. Luoxin Recent Developments
    Table 119. Halfsky Pharmacy Basic Information List
    Table 120. Halfsky Pharmacy Description and Business Overview
    Table 121. Halfsky Pharmacy Oxaliplatin Products, Services and Solutions
    Table 122. Revenue (US$ Million) in Oxaliplatin Business of Halfsky Pharmacy (2018-2023)
    Table 123. Halfsky Pharmacy Recent Developments
    Table 124. YRPG Basic Information List
    Table 125. YRPG Description and Business Overview
    Table 126. YRPG Oxaliplatin Products, Services and Solutions
    Table 127. Revenue (US$ Million) in Oxaliplatin Business of YRPG (2018-2023)
    Table 128. YRPG Recent Developments
    Table 129. Hainan Jinrui Pharmaceutical Basic Information List
    Table 130. Hainan Jinrui Pharmaceutical Description and Business Overview
    Table 131. Hainan Jinrui Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 132. Revenue (US$ Million) in Oxaliplatin Business of Hainan Jinrui Pharmaceutical (2018-2023)
    Table 133. Hainan Jinrui Pharmaceutical Recent Developments
    Table 134. Jari Pharmaceutical Basic Information List
    Table 135. Jari Pharmaceutical Description and Business Overview
    Table 136. Jari Pharmaceutical Oxaliplatin Products, Services and Solutions
    Table 137. Revenue (US$ Million) in Oxaliplatin Business of Jari Pharmaceutical (2018-2023)
    Table 138. Jari Pharmaceutical Recent Developments
    Table 139. Chiatai Tianqing Basic Information List
    Table 140. Chiatai Tianqing Description and Business Overview
    Table 141. Chiatai Tianqing Oxaliplatin Products, Services and Solutions
    Table 142. Revenue (US$ Million) in Oxaliplatin Business of Chiatai Tianqing (2018-2023)
    Table 143. Chiatai Tianqing Recent Developments
    Table 144. North America Oxaliplatin Market Size by Country (2018-2023) & (US$ Million)
    Table 145. North America Oxaliplatin Market Size by Country (2024-2029) & (US$ Million)
    Table 146. Europe Oxaliplatin Market Size by Country (2018-2023) & (US$ Million)
    Table 147. Europe Oxaliplatin Market Size by Country (2024-2029) & (US$ Million)
    Table 148. Asia-Pacific Oxaliplatin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 149. Asia-Pacific Oxaliplatin Market Size by Region (2018-2023) & (US$ Million)
    Table 150. Asia-Pacific Oxaliplatin Market Size by Region (2024-2029) & (US$ Million)
    Table 151. Asia-Pacific Oxaliplatin Market Share by Region (2018-2023)
    Table 152. Asia-Pacific Oxaliplatin Market Share by Region (2024-2029)
    Table 153. Latin America Oxaliplatin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 154. Latin America Oxaliplatin Market Size by Country (2018-2023) & (US$ Million)
    Table 155. Latin America Oxaliplatin Market Size by Country (2024-2029) & (US$ Million)
    Table 156. Middle East & Africa Oxaliplatin Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 157. Middle East & Africa Oxaliplatin Market Size by Country (2018-2023) & (US$ Million)
    Table 158. Middle East & Africa Oxaliplatin Market Size by Country (2024-2029) & (US$ Million)
    Table 159. Oxaliplatin Market Trends
    Table 160. Oxaliplatin Market Drivers
    Table 161. Oxaliplatin Market Challenges
    Table 162. Oxaliplatin Market Restraints
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Oxaliplatin Market Size Year-over-Year 2018-2029 & (US$ Million)
    Figure 2. Global Oxaliplatin Market Size (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Oxaliplatin Market Share by Regions: 2022 VS 2029
    Figure 4. Global Oxaliplatin Forecasted Market Size Share by Region (2024-2029)
    Figure 5. North America Oxaliplatin Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 6. Europe Oxaliplatin Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 7. Asia-Pacific Oxaliplatin Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 8. Latin America Oxaliplatin Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 9. Middle East & Africa Oxaliplatin Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 10. Product Picture of Mannitol
    Figure 11. Global Mannitol Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 12. Product Picture of Glucose Solution
    Figure 13. Global Glucose Solution Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 14. Product Picture of Lactose Solution
    Figure 15. Global Lactose Solution Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 16. Product Picture of Others
    Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 18. Global Oxaliplatin Market Size Share by Type:  2022 & 2029
    Figure 19. North America Oxaliplatin Revenue Market Share by Type (2018-2029)
    Figure 20. Europe Oxaliplatin Revenue Market Share by Type (2018-2029)
    Figure 21. Asia-Pacific Oxaliplatin Revenue Market Share by Type (2018-2029)
    Figure 22. Latin America Oxaliplatin Revenue Market Share by Type (2018-2029)
    Figure 23. Middle East and Africa Oxaliplatin Revenue Market Share by Type (2018-2029)
    Figure 24. Colorectal Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 25. Stomach Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 26. Ovarian Cancer Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 27. Others Market Size (US$ Million) & YoY Growth (2018-2029)
    Figure 28. Global Oxaliplatin Market Size Share by Application: 2022 & 2029
    Figure 29. North America Oxaliplatin Revenue Market Share by Application (2018-2029)
    Figure 30. Europe Oxaliplatin Revenue Market Share by Application (2018-2029)
    Figure 31. Asia-Pacific Oxaliplatin Revenue Market Share by Application (2018-2029)
    Figure 32. Latin America Oxaliplatin Revenue Market Share by Application (2018-2029)
    Figure 33. Middle East and Africa Oxaliplatin Revenue Market Share by Application (2018-2029)
    Figure 34. Oxaliplatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
    Figure 35. Global Top 5 and Top 10 Players Oxaliplatin Market Share in 2022
    Figure 36. North America Oxaliplatin Market Share by Country (2018-2029)
    Figure 37. U.S. Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 38. Canada Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 39. Germany Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 40. France Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 41. U.K. Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 42. Italy Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 43. Russia Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 44. Nordic Countries Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 45. Asia-Pacific Oxaliplatin Market Share by Region (2018-2029)
    Figure 46. China Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 47. Japan Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 48. South Korea Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 49. Southeast Asia Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 50. India Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 51. Australia Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 52. Latin America Oxaliplatin Market Share by Country (2018-2029)
    Figure 53. Mexico Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 54. Brazil Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 55. Middle East & Africa Oxaliplatin Market Share by Country (2018-2029)
    Figure 56. Turkey Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 57. Saudi Arabia Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 58. UAE Oxaliplatin Market Size (2018-2029) & (US$ Million)
    Figure 59. Bottom-up and Top-down Approaches for This Report

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

Europe is the largest market with about 33% market share. Followed by Japan, accounting for about 30% revenue market share.

Segment by Type
Mannitol
Glucose Solution
Lactose Solution
Others

Segment by Application
Colorectal Cancer
Stomach Cancer
Ovarian Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE

Industry: Pharma & Healthcare

Published: 2023-05-24

Pages: 122 Pages

Report ld: 1207621

Request Sample

Pre-Order Enquiry

CHOOSE LICENSE TYPE

Single User License

USD 3350.00

Multi Users License

USD 5025.00

Corporate Users License

USD 6700.00

/uploads/payment/payIcon/masterCard-01.svg

/uploads/payment/payIcon/american-express-01.svg

/uploads/payment/payIcon/diners-club-01.svg

/uploads/payment/payIcon/discover-4-01.svg

Add to Cart

Buy Now

A comprehensive and in-depth analysis of current industry data on markets, competitors and suppliers.

In-depth research on key industry players and analysis of production and sales operations.

Objective forecasts of future trends in the industry.

Speak To Our Analyst >>

WHAT QYRESEARCH OFFER?